AG˹ٷ

STOCK TITAN

Delisting of Securities from The Nasdaq Stock Market

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Negative)
Tags

Nasdaq (NASDAQ:NDAQ) has announced the delisting of securities from multiple companies from its exchange. The announcement affects 14 different companies whose securities have been suspended from trading between April 2024 and July 2025.

The delistings include various types of securities such as American depositary shares, common stocks, ordinary shares, units, and warrants. Notable companies affected include Secoo Holding Limited, PaxMedica, Unity Biotechnology, and Ocean Biomedical. All affected securities have already been suspended and haven't traded on Nasdaq since their respective suspension dates.

Further information about Nasdaq's delisting procedures can be found in the Nasdaq Rule 5800 Series on their website.

Nasdaq (NASDAQ:NDAQ) ha annunciato la cancellazione dalla quotazione di titoli di diverse società sul suo mercato. L'annuncio riguarda 14 diverse società i cui titoli sono stati sospesi dalla negoziazione tra aprile 2024 e luglio 2025.

Le cancellazioni comprendono vari tipi di titoli come American depositary shares, azioni ordinarie, unità e warrant. Tra le società più rilevanti coinvolte ci sono Secoo Holding Limited, PaxMedica, Unity Biotechnology e Ocean Biomedical. Tutti i titoli interessati sono già stati sospesi e non sono più stati negoziati sul Nasdaq dalla data di sospensione.

Ulteriori informazioni sulle procedure di delisting di Nasdaq sono disponibili nella Serie di Regole 5800 di Nasdaq sul loro sito web.

Nasdaq (NASDAQ:NDAQ) ha anunciado la exclusión de valores de varias compañías de su bolsa. El anuncio afecta a 14 compañías diferentes cuyos valores han sido suspendidos de negociación entre abril de 2024 y julio de 2025.

Las exclusiones incluyen diversos tipos de valores como acciones depositarias americanas, acciones ordinarias, unidades y warrants. Entre las compañías destacadas afectadas están Secoo Holding Limited, PaxMedica, Unity Biotechnology y Ocean Biomedical. Todos los valores afectados ya han sido suspendidos y no se han negociado en Nasdaq desde sus respectivas fechas de suspensión.

Más información sobre los procedimientos de exclusión de Nasdaq se puede encontrar en la Serie de Reglas 5800 de Nasdaq en su sitio web.

나스� (NASDAQ:NDAQ)은 여러 기업� 증권� 거래소에� 상장 폐지한다� 발표했습니다. 이번 발표� 2024� 4월부� 2025� 7� 사이� 거래가 정지� 14� 회사� 증권� 영향� 미칩니다.

상장 폐지 대상에� 미국 예탁 증서, 보통�, 단위 증권, 워런� � 다양� 종류� 증권� 포함됩니�. 주요 대� 기업으로� Secoo Holding Limited, PaxMedica, Unity Biotechnology, Ocean Biomedical 등이 있습니다. 영향� 받는 모든 증권은 이미 거래가 정지되었으며, 정지� 이후 나스닥에� 거래되지 않았습니�.

나스닥의 상장 폐지 절차� 관� 자세� 내용은 나스� 웹사이트� � 5800 시리즈에� 확인� � 있습니다.

Nasdaq (NASDAQ:NDAQ) a annoncé la radiation de titres de plusieurs sociétés de sa bourse. Cette annonce concerne 14 sociétés différentes dont les titres ont été suspendus de la négociation entre avril 2024 et juillet 2025.

Les radiations concernent divers types de titres tels que actions déposées américaines, actions ordinaires, unités et warrants. Parmi les sociétés notables affectées figurent Secoo Holding Limited, PaxMedica, Unity Biotechnology et Ocean Biomedical. Tous les titres concernés ont déjà été suspendus et n’ont pas été négociés sur Nasdaq depuis leurs dates de suspension respectives.

Des informations supplémentaires sur les procédures de radiation de Nasdaq sont disponibles dans la série de règles 5800 sur leur site internet.

Nasdaq (NASDAQ:NDAQ) hat die Delistung von Wertpapieren mehrerer Unternehmen von seiner Börse angekündigt. Die Ankündigung betrifft 14 verschiedene Unternehmen, deren Wertpapiere zwischen April 2024 und Juli 2025 vom Handel ausgesetzt wurden.

Zu den Delistings gehören verschiedene Wertpapiertypen wie American Depositary Shares, Stammaktien, Einheiten und Warrants. Bedeutende betroffene Unternehmen sind Secoo Holding Limited, PaxMedica, Unity Biotechnology und Ocean Biomedical. Alle betroffenen Wertpapiere wurden bereits ausgesetzt und wurden seit ihren jeweiligen Aussetzungsterminen nicht mehr an der Nasdaq gehandelt.

Weitere Informationen zu den Delisting-Verfahren der Nasdaq finden Sie in der Nasdaq-Regelreihe 5800 auf deren Webseite.

Positive
  • None.
Negative
  • Mass delisting of 14 companies indicates significant compliance or performance issues with listed entities
  • Multiple biotechnology and healthcare companies being delisted suggests increased risks in these sectors
  • The wide range of security types affected (ADRs, common stocks, warrants) shows broad-based listing standard failures

Insights

Nasdaq announced the formal delisting of securities from 14 companies that were already suspended from trading, indicating serious compliance issues across diverse sectors.

Nasdaq has formalized the delisting of securities from 14 different companies spanning various sectors, including biotech, technology, and education. All these securities had been previously suspended from trading for periods ranging from several weeks to over a year before this official delisting announcement. Notable companies affected include TC BioPharm, Unity Biotechnology, Ocean Biomedical, and Secoo Holding.

This mass delisting action indicates these companies failed to meet Nasdaq's continued listing requirements, which typically involve maintaining minimum bid prices (usually $1 per share), adequate market capitalization, timely financial reporting, and corporate governance standards. Once delisted, these securities will likely move to over-the-counter (OTC) markets, where they face substantially reduced liquidity, diminished investor protection regulations, and typically lower valuations.

For existing shareholders, this formalization of delisting following suspensions represents the culmination of a downward trajectory, with significantly impaired ability to exit positions at favorable prices. The diverse nature of affected companies—from biotechnology firms to SPACs—suggests widespread compliance issues rather than sector-specific challenges. This delisting wave serves as a reminder of Nasdaq's regulatory enforcement mechanisms and the substantial consequences for companies failing to maintain compliance with exchange standards.

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the American depositary shares of Secoo Holding Limited. Secoo Holding Limited’s security was suspended on April 26, 2024 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of PaxMedica, Inc. PaxMedica, Inc.’s common stock was suspended on May 2, 2024 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist ordinary shares of Etao International Co, Ltd. Etao International Co., Ltd.’s security was suspended on May 9, 2024 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist common stock, units, and warrants of Future Health ESG Corp. Future Health ESG Corp.’s securities were suspended on May 21, 2024 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, warrants, and units of Aetherium Acquisition Corp. Aetherium Acquisition Corp.’s securities were suspended on June 21, 2024 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist common stock and warrants of OpGen, Inc. OpGen, Inc.’s securities were suspended on August 20, 2024 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American depositary shares and warrants of TC BioPharm (Holdings) plc. TC BioPharm (Holdings) plc’s securities were suspended on March 24, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock of Nxu, Inc. Nxu, Inc. ’s stock was suspended on April 10, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of Ocean Biomedical, Inc. Ocean Biomedical, Inc.’s securities were suspended on April 24, 2025 and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Baijiayun Group Ltd. Baijiayun Group Ltd’s security was suspended on May 15, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of iCoreConnect Inc. iCoreConnect Inc.’s common stock was suspended on May 22, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of LogicMark, Inc. LogicMark, Inc.’s common stock was suspended on June 2, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of China Liberal Education Holdings Limited. China Liberal Education Holdings Limited’s security was suspended on June 3, 2025 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist common stock of Unity Biotechnology, Inc. Unity Biotechnology, Inc.’s common stock was suspended on July 9, 2025 and has not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .


FAQ

How many companies are being delisted from Nasdaq in August 2025?

14 companies are being delisted from Nasdaq, including various types of securities such as American depositary shares, common stocks, ordinary shares, units, and warrants.

What types of companies are affected by the Nasdaq delisting announcement?

The delisting affects various companies, including biotechnology firms (Unity Biotechnology, TC BioPharm, Ocean Biomedical), technology companies (iCoreConnect), and international firms (Secoo Holding, China Liberal Education Holdings).

When were these companies initially suspended from trading on Nasdaq?

The companies were suspended at different times between April 2024 and July 2025, with none of them trading on Nasdaq since their respective suspension dates.

Where can investors find Nasdaq's rules regarding security delistings?

Investors can find Nasdaq's delisting rules in the Nasdaq Rule 5800 Series, available on their website at https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

What happens to shares of companies after they are delisted from Nasdaq?

After delisting from Nasdaq, shares typically move to over-the-counter (OTC) markets if they meet requirements, but they lose the benefits of major exchange listing including reduced liquidity, institutional investment access, and trading visibility.
Nasdaq Inc

NASDAQ:NDAQ

NDAQ Rankings

NDAQ Latest News

NDAQ Latest SEC Filings

NDAQ Stock Data

55.28B
428.33M
10.72%
84.22%
1.02%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
United States
NEW YORK